The Accelerator will keep U-Protein Express in pace with in contract research business by giving 3-4 times current capacity.
The J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry.
Revenue ImmunoPrecise achieved a 16% rise in revenue for the three-month period.
Talem has the right to develop and partner fully human antibodies in OmniRat®, OmniFlic®, OmniMouse®, OmniChicken®, and OmniClic™.
Mr. Lundstrom has established global business leadership in transgenic animals for discovery of human therapeutic antibodies with Ligand Pharmaceuticals Inc.